Patents Assigned to Synchroneuron Inc.
  • FORMULATIONS
    Publication number: 20220184007
    Abstract: Provided herein are high-dose formulations of acamprosate in a pharmaceutically acceptable salt form, as well as methods of preparing the same, and methods of using the same.
    Type: Application
    Filed: April 2, 2020
    Publication date: June 16, 2022
    Applicant: Synchroneuron Inc.
    Inventors: Barry S. Fogel, William D. Kerns, DVM, MS, DACVP, Kei-Lai Fong
  • Methods of treating posttraumatic stress disorder with acamprosate salts
    Patent number: 10512621
    Abstract: Embodiments disclosed herein generally relate to methods of treating posttraumatic stress disorder (PTSD) using acamprosate formulations and/or acamprosate formulations in combination with at least one other medication, such as neuroleptic (antipsychotic) and/or antidepressant drugs.
    Type: Grant
    Filed: July 15, 2016
    Date of Patent: December 24, 2019
    Assignee: Synchroneuron, Inc.
    Inventors: Barry S. Fogel, William D. Kerns, Kei-Lai Fong
  • Acamprosate formulations, methods of using the same, and combinations comprising the same
    Patent number: 10166207
    Abstract: Embodiments disclosed herein generally relate to acamprosate formulations, methods of use of the formulations, to methods of using the formulations optionally in combination with at least one other medication, and to combination products and compositions comprising acamprosate and at least one other medication, such as neuroleptic (antipsychotic) and/or antidepressant drugs.
    Type: Grant
    Filed: June 5, 2014
    Date of Patent: January 1, 2019
    Assignee: Synchroneuron, Inc.
    Inventors: Barry S. Fogel, William D. Kerns, Kei-Lai Fong
  • Acamprosate formulations, methods of using the same, and combinations comprising the same
    Patent number: 9427420
    Abstract: Embodiments disclosed herein generally relate to acamprosate formulations, methods of use of the formulations, to methods of using the formulations in combination with at least one other medication, and to combination products and compositions comprising the formulations and at least one other medication, such as neuroleptic (antipsychotic) and/or antidepressant drugs.
    Type: Grant
    Filed: June 5, 2014
    Date of Patent: August 30, 2016
    Assignee: Synchroneuron, Inc.
    Inventors: Barry S. Fogel, William D. Kerns, Kei-Lai Fong, San-Laung Chow, Edward Lin, David Wong
  • Acamprosate formulations, methods of using the same, and combinations comprising the same
    Patent number: 9421179
    Abstract: Embodiments disclosed herein generally relate to acamprosate formulations, methods of use of the formulations, to methods of using the formulations in combination with at least one other medication, and to combination products and compositions comprising the formulations and at least one other medication, such as neuroleptic (antipsychotic) and/or antidepressant drugs.
    Type: Grant
    Filed: May 9, 2013
    Date of Patent: August 23, 2016
    Assignee: Synchroneuron, Inc.
    Inventors: Barry S. Fogel, William D. Kerns, Kei-Lai Fong
  • Acamprosate formulations, methods of using the same, and combinations comprising the same
    Patent number: 9421178
    Abstract: Embodiments disclosed herein generally relate to acamprosate formulations, methods of use of the formulations, to methods of using the formulations in combination with at least one other medication, and to combination products and compositions comprising the formulations and at least one other medication, such as neuroleptic (antipsychotic) and/or antidepressant drugs.
    Type: Grant
    Filed: May 9, 2013
    Date of Patent: August 23, 2016
    Assignee: Synchroneuron, Inc.
    Inventors: Barry S. Fogel, William D. Kerns, Kei-Lai Fong
  • ACAMPROSATE FORMULATIONS, METHODS OF USING THE SAME, AND COMBINATIONS COMPRISING THE SAME
    Publication number: 20160101075
    Abstract: Embodiments disclosed herein generally relate to acamprosate formulations, methods of use of the formulations, to methods of using the formulations optionally in combination with at least one other medication, and to combination products and compositions comprising acamprosate and at least one other medication, such as neuroleptic (antipsychotic) and/or antidepressant drugs.
    Type: Application
    Filed: June 5, 2014
    Publication date: April 14, 2016
    Applicant: SYNCHRONEURON, INC.
    Inventors: Barry S. Fogel, William D. Kerns, Kei-Lai Fong, San-Laung Chow, David Wong, Edward Lin
  • ACAMPROSATE FORMULATIONS, METHODS OF USING THE SAME, AND COMBINATIONS COMPRISING THE SAME
    Publication number: 20130310455
    Abstract: Embodiments disclosed herein generally relate to acamprosate formulations, methods of use of the formulations, to methods of using the formulations in combination with at least one other medication, and to combination products and compositions comprising the formulations and at least one other medication, such as neuroleptic (antipsychotic) and/or antidepressant drugs.
    Type: Application
    Filed: May 9, 2013
    Publication date: November 21, 2013
    Applicant: Synchroneuron Inc.
    Inventor: Synchroneuron Inc.
  • ACAMPROSATE FORMULATIONS, METHODS OF USING THE SAME, AND COMBINATIONS COMPRISING THE SAME
    Publication number: 20130310456
    Abstract: Embodiments disclosed herein generally relate to acamprosate formulations, methods of use of the formulations, to methods of using the formulations in combination with at least one other medication, and to combination products and compositions comprising the formulations and at least one other medication, such as neuroleptic (antipsychotic) and/or antidepressant drugs.
    Type: Application
    Filed: May 9, 2013
    Publication date: November 21, 2013
    Applicant: Synchroneuron Inc.
    Inventor: Synchroneuron Inc.
  • ACAMPROSATE FORMULATIONS, METHODS OF USING THE SAME, AND COMBINATIONS COMPRISING THE SAME
    Publication number: 20130245004
    Abstract: Embodiments disclosed herein generally relate to acamprosate formulations, methods of use of the formulations, to methods of using the formulations in combination with at least one other medication, and to combination products and compositions comprising the formulations and at least one other medication, such as neuroleptic (antipsychotic) and/or antidepressant drugs.
    Type: Application
    Filed: May 9, 2013
    Publication date: September 19, 2013
    Applicant: Synchroneuron Inc.
    Inventors: Barry S. Fogel, William D. Kerns, Kei-Lai Fong
  • ACAMPROSATE FORMULATIONS, METHODS OF USING THE SAME, AND COMBINATIONS COMPRISING THE SAME
    Publication number: 20130224292
    Abstract: Embodiments disclosed herein generally relate to acamprosate formulations, methods of use of the formulations, to methods of using the formulations in combination with at least one other medication, and to combination products and compositions comprising the formulations and at least one other medication, such as neuroleptic (antipsychotic) and/or antidepressant drugs.
    Type: Application
    Filed: March 29, 2013
    Publication date: August 29, 2013
    Applicant: Synchroneuron Inc.
    Inventor: Synchroneuron Inc.